HealthEquity (NASDAQ:HQY) Price Target Raised to $120.00 at Barrington Research

HealthEquity (NASDAQ:HQY) had its price objective hoisted by Barrington Research from $105.00 to $120.00 in a research report sent to investors on Monday,Benzinga reports. The firm currently has an outperform rating on the stock.

Several other brokerages have also recently weighed in on HQY. JMP Securities reissued a “market outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. BTIG Research upped their target price on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. Bank of America lifted their target price on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Finally, The Goldman Sachs Group began coverage on shares of HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 target price for the company. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $108.38.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $101.66 on Monday. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity has a twelve month low of $62.10 and a twelve month high of $105.82. The business’s 50 day moving average price is $90.16 and its two-hundred day moving average price is $82.85. The company has a market cap of $8.88 billion, a PE ratio of 84.62, a price-to-earnings-growth ratio of 1.59 and a beta of 0.52.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The firm had revenue of $299.93 million for the quarter, compared to analyst estimates of $284.48 million. On average, analysts predict that HealthEquity will post 2.27 EPS for the current year.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the transaction, the director now owns 54,719 shares of the company’s stock, valued at approximately $4,540,582.62. This represents a 13.10 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Frank Corvino sold 1,247 shares of the business’s stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the sale, the director now owns 4,823 shares of the company’s stock, valued at approximately $387,093.98. This represents a 20.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 10,536 shares of company stock worth $884,517. Insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

A number of institutional investors and hedge funds have recently made changes to their positions in HQY. Price T Rowe Associates Inc. MD lifted its position in HealthEquity by 7.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 51,384 shares of the company’s stock valued at $4,195,000 after purchasing an additional 3,365 shares in the last quarter. GAMMA Investing LLC lifted its holdings in HealthEquity by 114.8% during the second quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock valued at $51,000 after purchasing an additional 318 shares in the last quarter. CWM LLC lifted its holdings in HealthEquity by 6.9% during the second quarter. CWM LLC now owns 3,958 shares of the company’s stock valued at $341,000 after purchasing an additional 255 shares in the last quarter. SG Americas Securities LLC increased its stake in shares of HealthEquity by 48.5% in the second quarter. SG Americas Securities LLC now owns 3,798 shares of the company’s stock worth $327,000 after purchasing an additional 1,241 shares in the last quarter. Finally, Sequoia Financial Advisors LLC bought a new stake in shares of HealthEquity during the 2nd quarter valued at $1,122,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.